Fund Universe

← Fund Universe

☆Propel Bio Management, LLC

CIK 0001969764 · holdings for 2026Q2 (change vs 2026Q1) · in signal universe
Quality Q
0.225
AUM ($M)
191
Positions
29
Turnover
0.25
Top-10 wt
68%
Herfindahl
0.071
History (qtrs)
6
Excess Return
not eligible

AI Eval Run AI Eval

No AI Eval requested yet for this fund.
Quarter
Activity this period
Security type

Holdings · 42 positions · portfolio value $191M

TickerNameActivitySecurity Type WeightΔ Weight Value ($M)SharesΔ Shares Qtrs HeldExcess Return
☆PAGP funds › PLAINS GP HOLDINGS LP-CL HOLD — 16.2% -2.9% 30.9 1,272,360 +0 5 —
☆ACHV funds › ACHIEVE LIFE SCIENCES INC ADD — 13.8% +6.6% 26.3 4,034,018 +247,593 5 —
☆CORT funds › CORCEPT THERAPEUTICS INC TRIM — 6.2% +2.4% 11.9 136,499 -11,329 2 —
☆PHAT funds › PHATHOM PHARMACEUTICALS I ADD — 6.0% +0.1% 11.4 1,050,358 +209,086 5 —
☆DCTH funds › DELCATH SYSTEMS INC TRIM — 5.7% -0.0% 11.0 871,460 -108,238 5 —
☆MIST funds › MILESTONE PHARMACEUTICALS ADD — 5.2% +2.0% 10.0 7,429,590 +3,311,269 5 —
☆CMPS funds › COMPASS PATHWAYS PLC TRIM — 4.2% +1.6% 8.1 573,086 -168,963 4 —
☆KYTX funds › KYVERNA THERAPEUTICS INC ADD — 4.1% +0.6% 7.9 883,198 +238,777 3 —
☆ARTV funds › ARTIVA BIOTHERAPEUTICS IN ADD — 3.5% +2.9% 6.8 696,436 +550,067 2 —
☆ABEO funds › ABEONA THERAPEUTICS INC TRIM — 3.2% -0.6% 6.1 983,070 -346,829 5 —
☆AQST funds › AQUESTIVE THERAPEUTICS IN ADD — 3.1% +1.3% 6.0 1,442,397 +731,409 2 —
☆PALI funds › PALISADE BIO INC ADD — 2.8% +1.6% 5.4 2,582,388 +1,467,388 2 —
☆IMUX funds › IMMUNIC INC NEW — 2.6% +2.6% 5.0 325,022 +325,022 1 —
☆IVA funds › INVENTIVA SA - ADR ADD — 2.5% +0.0% 4.8 1,281,212 +556,534 3 —
☆SABS funds › SAB BIOTHERAPEUTICS INC ADD — 2.2% -0.3% 4.2 1,076,578 +63,788 3 —
☆OBIO funds › ORCHESTRA BIOMED HOLDINGS HOLD — 2.0% -0.4% 3.9 896,701 +0 2 —
☆CLDX funds › CELLDEX THERAPEUTICS INC TRIM — 2.0% -0.6% 3.9 103,695 -27,669 4 —
☆ZVRA funds › ZEVRA THERAPEUTICS INC TRIM — 1.9% +0.2% 3.6 253,544 -28,874 5 —
☆OCUL funds › OCULAR THERAPEUTIX INC TRIM — 1.8% -0.2% 3.5 357,966 -24,409 2 —
☆FDMT funds › 4D MOLECULAR THERAPEUTICS IN TRIM — 1.8% -0.5% 3.4 252,654 -127,766 2 —
☆OVID funds › OVID THERAPEUTICS INC ADD — 1.6% +0.3% 3.0 1,115,538 +194,081 2 —
☆EYPT funds › EYEPOINT INC TRIM — 1.4% -0.3% 2.7 191,745 -24,080 2 —
☆UPB funds › UPSTREAM BIO INC ADD — 1.3% -0.7% 2.4 350,389 +8,610 2 —
☆SCYX funds › SCYNEXIS INC NEW — 1.2% +1.2% 2.2 543,478 +543,478 1 —
☆SLN funds › SILENCE THERAPEUTICS PLC NEW — 1.1% +1.1% 2.1 191,733 +191,733 1 —
☆LONA funds › LEONABIO INC HOLD — 0.7% -0.2% 1.4 149,279 +0 4 —
☆MAZE funds › MAZE THERAPEUTICS INC HOLD — 0.7% -0.1% 1.3 43,798 +0 2 —
☆CRVS funds › CORVUS PHARMACEUTICALS INC TRIM — 0.6% -0.2% 1.1 70,380 -15,411 2 —
☆SGMT funds › SAGIMET BIOSCIENCES INC-A NEW — 0.5% +0.5% 1.0 125,878 +125,878 1 —
☆KLRS funds › KALARIS THERAPEUTICS INC EXIT — 0.0% -1.1% 0.0 0 -295,771 0 —
☆ALDX funds › ALDEYRA THERAPEUTICS INC EXIT — 0.0% -0.8% 0.0 0 -730,606 0 —
☆CNTB funds › CONNECT BIOPHARMA HLDGS LTD EXIT — 0.0% -0.3% 0.0 0 -209,493 0 —
☆TRVI funds › TREVI THERAPEUTICS INC EXIT — 0.0% -1.7% 0.0 0 -223,802 0 —
☆VOR funds › VOR BIOPHARMA INC EXIT — 0.0% -3.5% 0.0 0 -314,543 0 —
☆CUSIP:4525EP101 funds › IMMUNIC INC EXIT — 0.0% -1.7% 0.0 0 -2,344,779 0 —
☆NUVB funds › NUVATION BIO INC EXIT — 0.0% -0.9% 0.0 0 -329,296 0 —
☆QURE funds › UNIQURE NV EXIT — 0.0% -1.1% 0.0 0 -104,772 0 —
☆MSLE funds › SATELLOS BIOSCIENCE INC EXIT — 0.0% -0.0% 0.0 0 -10,145 0 —
☆VRDN funds › VIRIDIAN THERAPEUTICS INC EXIT — 0.0% -2.6% 0.0 0 -210,163 0 —
☆CHRS funds › COHERUS ONCOLOGY INC EXIT — 0.0% -1.5% 0.0 0 -1,420,550 0 —
☆OCS funds › OCULIS HOLDING AG EXIT — 0.0% -2.1% 0.0 0 -122,223 0 —
☆EVMN funds › EVOMMUNE INC EXIT — 0.0% -0.8% 0.0 0 -55,664 0 —

Point-in-time history

Each row is this fund as of that period, not as of today — what the scoring for that quarter actually saw.
PeriodAUM ($M)Positions TurnoverTop-10 wtHerfindahl Quality Q Skill Universe
2026Q2 191 29 0.25 68% 0.071 0.225 — in
2026Q1 159 38 0.37 58% 0.063 0.063 — in
2025Q4 117 20 0.34 84% 0.104 0.143 — in
2025Q3 100 16 0.24 87% 0.110 0.281 — in
2025Q2 82 16 0.25 98% 0.164 0.368 — entered
2025Q1 86 18 0.00 92% 0.149 0.000 — out
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status